Literature DB >> 23273600

Investigation of C9orf72 repeat expansions in Parkinson's disease.

Hussein Daoud1, Anne Noreau, Daniel Rochefort, Gabriel Paquin-Lanthier, Maude Turcotte Gauthier, Pierre Provencher, Emmanuelle Pourcher, Nicolas Dupré, Sylvain Chouinard, Nicolas Jodoin, Valérie Soland, Edward A Fon, Patrick A Dion, Guy A Rouleau.   

Abstract

Large repeat expansions in the C9orf72 gene were recently reported to be a major cause of familial amyotrophic lateral sclerosis and frontotemporal dementia. Given some of the clinical and pathologic overlap between these 2 diseases and Parkinson's disease, we sought to evaluate the presence of these expansions in a cohort of French-Canadian patients with Parkinson's disease. No pathologic expansion was found in our cohort of patients suggesting that C9orf72 repeat expansions do not play a major role in the pathogenesis of Parkinson's disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273600     DOI: 10.1016/j.neurobiolaging.2012.11.025

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

1.  C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.

Authors:  Antonino Cannas; Paolo Solla; Giuseppe Borghero; Gian Luca Floris; Adriano Chio; Marcello Mario Mascia; Nicola Modugno; Antonella Muroni; Gianni Orofino; Francesca Di Stefano; Andrea Calvo; Cristina Moglia; Gabriella Restagno; Mario Meloni; Rita Farris; Daniela Ciaccio; Roberta Puddu; Melisa Iris Vacca; Rosanna Melis; Maria Rita Murru; Stefania Tranquilli; Daniela Corongiu; Marcella Rolesu; Stefania Cuccu; Maria Giovanna Marrosu; Francesco Marrosu
Journal:  J Neurol       Date:  2015-08-15       Impact factor: 4.849

2.  C9ORF72 repeat expansions in cases with previously identified pathogenic mutations.

Authors:  Marka van Blitterswijk; Matthew C Baker; Mariely DeJesus-Hernandez; Roberta Ghidoni; Luisa Benussi; Elizabeth Finger; Ging-Yuek R Hsiung; Brendan J Kelley; Melissa E Murray; Nicola J Rutherford; Patricia E Brown; Thomas Ravenscroft; Bianca Mullen; Peter E A Ash; Kevin F Bieniek; Kimmo J Hatanpaa; Anna Karydas; Elisabeth McCarty Wood; Giovanni Coppola; Eileen H Bigio; Carol Lippa; Michael J Strong; Thomas G Beach; David S Knopman; Edward D Huey; Marsel Mesulam; Thomas Bird; Charles L White; Andrew Kertesz; Dan H Geschwind; Vivianna M Van Deerlin; Ronald C Petersen; Giuliano Binetti; Bruce L Miller; Leonard Petrucelli; Zbigniew K Wszolek; Kevin B Boylan; Neill R Graff-Radford; Ian R Mackenzie; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers
Journal:  Neurology       Date:  2013-09-11       Impact factor: 9.910

3.  C9ORF72 repeat expansions in Chinese patients with Parkinson's disease and multiple system atrophy.

Authors:  Xueping Chen; Yongping Chen; Qianqian Wei; Ruwei Ou; Bei Cao; Bi Zhao; Hui-Fang Shang
Journal:  J Neural Transm (Vienna)       Date:  2016-07-29       Impact factor: 3.575

Review 4.  Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

5.  Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease.

Authors:  Karen Nuytemans; Vanessa Inchausti; Gary W Beecham; Liyong Wang; Dennis W Dickson; John Q Trojanowski; Virginia M-Y Lee; Deborah C Mash; Matthew P Frosch; Tatiana M Foroud; Lawrence S Honig; Thomas J Montine; Ted M Dawson; Eden R Martin; William K Scott; Jeffery M Vance
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

Review 6.  C9ORF72 mutations in neurodegenerative diseases.

Authors:  Ying Liu; Jin-Tai Yu; Yu Zong; Jing Zhou; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

Review 7.  C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature.

Authors:  Thomas Bourinaris; Henry Houlden
Journal:  Mov Disord Clin Pract       Date:  2018-11-08

8.  Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.

Authors:  David M A Mann; Sara Rollinson; Andrew Robinson; Janis Bennion Callister; Jennifer C Thompson; Julie S Snowden; Tania Gendron; Leonard Petrucelli; Masami Masuda-Suzukake; Masato Hasegawa; Yvonne Davidson; Stuart Pickering-Brown
Journal:  Acta Neuropathol Commun       Date:  2013-10-14       Impact factor: 7.801

9.  Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.

Authors:  Jessie Theuns; Aline Verstraeten; Kristel Sleegers; Eline Wauters; Ilse Gijselinck; Stefanie Smolders; David Crosiers; Ellen Corsmit; Ellen Elinck; Manu Sharma; Rejko Krüger; Suzanne Lesage; Alexis Brice; Sun Ju Chung; Mi-Jung Kim; Young Jin Kim; Owen A Ross; Zbigniew K Wszolek; Ekaterina Rogaeva; Zhengrui Xi; Anthony E Lang; Christine Klein; Anne Weissbach; George D Mellick; Peter A Silburn; Georgios M Hadjigeorgiou; Efthimios Dardiotis; Nobutaka Hattori; Kotaro Ogaki; Eng-King Tan; Yi Zhao; Jan Aasly; Enza Maria Valente; Simona Petrucci; Grazia Annesi; Aldo Quattrone; Carlo Ferrarese; Laura Brighina; Angela Deutschländer; Andreas Puschmann; Christer Nilsson; Gaëtan Garraux; Mark S LeDoux; Ronald F Pfeiffer; Magdalena Boczarska-Jedynak; Grzegorz Opala; Demetrius M Maraganore; Sebastiaan Engelborghs; Peter Paul De Deyn; Patrick Cras; Marc Cruts; Christine Van Broeckhoven
Journal:  Neurology       Date:  2014-10-17       Impact factor: 9.910

10.  C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.

Authors:  Karen Nuytemans; Güney Bademci; Martin M Kohli; Gary W Beecham; Liyong Wang; Juan I Young; Fatta Nahab; Eden R Martin; John R Gilbert; Michael Benatar; Jonathan L Haines; William K Scott; Stephan Züchner; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Ann Hum Genet       Date:  2013-07-12       Impact factor: 1.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.